Persistence of mature dendritic cells, TH2A, and Tc2 cells characterize clinically resolved atopic dermatitis under IL-4Rα blockade.

MLA

Bangert, Christine, et al. “Persistence of Mature Dendritic Cells, TH2A, and Tc2 Cells Characterize Clinically Resolved Atopic Dermatitis under IL-4Rα Blockade.” Science Immunology, vol. 6, no. 55, Jan. 2021, pp. 1–16. EBSCOhost, https://doi.org/10.1126/sciimmunol.abe2749.

APA

Bangert, C., Rindler, K., Krausgruber, T., Alkon, N., Thaler, F. M., Kurz, H., Ayub, T., Demirtas, D., Fortelny, N., Vorstandlechner, V., Bauer, W. M., Quint, T., Mildner, M., Jonak, C., Elbe-Bürger, A., Griss, J., Bock, C., & Brunner, P. M. (2021). Persistence of mature dendritic cells, TH2A, and Tc2 cells characterize clinically resolved atopic dermatitis under IL-4Rα blockade. Science Immunology, 6(55), 1–16. https://doi.org/10.1126/sciimmunol.abe2749

Chicago

Bangert, Christine, Katharina Rindler, Thomas Krausgruber, Natalia Alkon, Felix M. Thaler, Harald Kurz, Tanya Ayub, et al. 2021. “Persistence of Mature Dendritic Cells, TH2A, and Tc2 Cells Characterize Clinically Resolved Atopic Dermatitis under IL-4Rα Blockade.” Science Immunology 6 (55): 1–16. doi:10.1126/sciimmunol.abe2749.